Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma

1 Jul 2017

Abstract excerpt

Hepatocellular carcinoma is one of the most mortal and prevalent cancers with increasing incidence worldwide. Elucidating genetic driver genes for prognosis and palindromia of hepatocellular carcinoma helps managing clinical decisions for patients. In this study, the high-throughput RNA sequencing data on platform IlluminaHiSeq of hepatocellular carcinoma were downloaded from The Cancer Genome Atlas with 330...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28718365
DOI: 10.1177/1010428317708900

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinomaPMID 28718365Read ↗

Based on Exosome-Derived Genes for Constructing Diagnostic, Prognostic and Recurrence Models and Predicting Therapeutic Response for Hepatocellular CarcinomaSemantic proximity Read ↗

Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma PrognosisSemantic proximity Read ↗

Differentially expressed liver exosome-related genes as a candidate prognostic biomarker for hepatocellular carcinomaSemantic proximity Read ↗

Identification of Immune-Related Target and Prognostic Biomarkers in PBMC of hepatocellular carcinomaSemantic proximity Read ↗

Exploring the Prognostic Value and Biological Function of CPNE1 Gene in Hepatocellular CarcinomaSemantic proximity Read ↗

Construction of a prognostic model and identification of key genes in liver hepatocellular carcinoma based on multi-omics dataSemantic proximity Read ↗

A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Four Metastasis-Related mRNAs Signature Predicting the Survival of Patients With Liver Hepatocellular CarcinomaSemantic proximity Read ↗

A Novel CCR7-Related Immune Prognostic Signature for Liver Hepatocellular Carcinoma (LIHC) Based on Immunogenomic ProfilingSemantic proximity Read ↗

Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysisSemantic proximity Read ↗

Investigation of Hippo pathway-related prognostic lncRNAs and molecular subtypes in liver hepatocellular carcinomaSemantic proximity Read ↗

Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.